These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4237560)

  • 21. [Plasmodium falciparum malaria resistant to polychemotherapy. Usefulness of pathogen culture (author's transl)].
    Dournon E; Le Bras J; Charmot G; Frottier J; Bastin R
    Nouv Presse Med; 1981 Oct; 10(39):3233-6. PubMed ID: 7029457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malaria suppression and prophylaxis on a Malaysian rubber estate: sulformethoxine-pyrimethamine single monthly dose vs chloroquine single weekly dose.
    O'Holohan DR; Hugoe-Matthews J
    Southeast Asian J Trop Med Public Health; 1971 Jun; 2(2):164-8. PubMed ID: 4944641
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol).
    Pearlman EJ; Doberstyn EB; Sudsok S; Thiemanun W; Kennedy RS; Canfield CJ
    Am J Trop Med Hyg; 1980 Nov; 29(6):1131-7. PubMed ID: 7004214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of malaria in Aligarh.
    Mehrunnisa A; Wajihullah ; Saifi MA; Khan HM
    J Commun Dis; 2002 Mar; 34(1):70-7. PubMed ID: 12718345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malaria treatment and prevention. A review.
    Hall SA
    East Afr Med J; 1969 Oct; 46(10):553-63. PubMed ID: 4905723
    [No Abstract]   [Full Text] [Related]  

  • 26. Multi-drug resistant malaria in Sri Lanka.
    Gunasekera DP; Perera DP
    Ceylon Med J; 1996 Dec; 41(4):170-1. PubMed ID: 9141768
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
    Marfurt J; de Monbrison F; Brega S; Barbollat L; Müller I; Sie A; Goroti M; Reeder JC; Beck HP; Picot S; Genton B
    J Infect Dis; 2008 Aug; 198(3):409-17. PubMed ID: 18582193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross resistance of pyrimethamine and sulfadoxine to their related compounds in Plasmodium falciparum.
    Tan-ariya P; Brockelman C
    Southeast Asian J Trop Med Public Health; 1984 Mar; 15(1):7-11. PubMed ID: 6377515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of sulphadoxine/pyrimethamine on gametocytes in falciparum malaria.
    Ittiravivongs A; Vasuvat C; Kongrod S
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):323-5. PubMed ID: 6395351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimalarial effects of sulphormethoxine, diaphenylsulphone and separate combinations of these with pyrimethamine: a review of preliminary investigations carried out in Tanzania.
    Laing AB
    J Trop Med Hyg; 1968 Feb; 71(2):27-35. PubMed ID: 4867507
    [No Abstract]   [Full Text] [Related]  

  • 31. Chloroquine resistance and Plasmodium falciparum in Punjab, Pakistan during 2000-2001.
    Rana MS; Tanveer A
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):288-91. PubMed ID: 15691126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The suppression of Plasmodium falciparum and Plasmodium vivax parasitaemias by a dapsone-pyrimethamine combination.
    Segal HE; Pearlman EJ; Thiemanun W; Castaneda BF; Ames CW
    J Trop Med Hyg; 1973 Nov; 76(11):285-90. PubMed ID: 4586093
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo sulphadoxine-pyrimethamine sentitivity study Tigray Region, Southern Zone, Alamata Town, September--November 2001.
    Degefa T
    Ethiop Med J; 2004 Jan; 42(1):35-9. PubMed ID: 15884275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malaria situation in several villages around Timika, south central Irian Jaya, Indonesia.
    Pribadi W; Sutanto I; Atmosoedjono S; Rasidi R; Surya LK; Susanto L
    Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):228-35. PubMed ID: 9886103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some pharmacological aspects of antimalarial drugs.
    Botha D
    S Afr Med J; 1974 Jun; 48(29):1263-5. PubMed ID: 4607434
    [No Abstract]   [Full Text] [Related]  

  • 36. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
    De Geus A; Meuwissen JH; van Rijn A
    Trop Geogr Med; 1982; 34(3):261-3. PubMed ID: 6758245
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotherapy of malaria.
    Rozman RS
    Annu Rev Pharmacol; 1973; 13():127-52. PubMed ID: 4576886
    [No Abstract]   [Full Text] [Related]  

  • 38. Fansidar resistant Plasmodium falciparum infection in Surinam.
    Oostburg BF; Jozefzoon LM
    Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
    Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Trial prevention of paludisine through monthly absorption of pyrimethamine-sulfomethoxine].
    Riche A; Colombo P
    Bull Soc Pathol Exot Filiales; 1971; 64(6):847-56. PubMed ID: 4949451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.